{
  "ticker": "GLPG",
  "company_name": "Galapagos NV",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02562859",
      "title": "Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2015-09",
      "completion_date": "2015-10",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT03711162",
      "title": "A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Idiopathic Pulmonary Fibrosis",
      "start_date": "2018-11-28",
      "completion_date": "2021-03-30",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT03540524",
      "title": "A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Cystic Fibrosis",
      "start_date": "2018-05-31",
      "completion_date": "2019-03-11",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT01894516",
      "title": "Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2013-10-08",
      "completion_date": "2015-05-29",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT02690519",
      "title": "Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Cystic Fibrosis",
      "start_date": "2016-01",
      "completion_date": "2016-09",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT04985435",
      "title": "Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH)",
      "status": "RECRUITING",
      "phase": "PHASE4",
      "condition": "Rheumatoid Arthritis",
      "start_date": "2021-05-12",
      "completion_date": "2025-09-30",
      "enrollment": 0,
      "sponsor": "R.Bos"
    },
    {
      "nct_id": "NCT02612246",
      "title": "First-in-Human Single and Multiple Dose of GLPG1972",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2015-11",
      "completion_date": "2016-07",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT01336244",
      "title": "GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2011-04",
      "completion_date": "2011-09",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT01721980",
      "title": "Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2012-10",
      "completion_date": "2013-02",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    },
    {
      "nct_id": "NCT01915667",
      "title": "Oral Bioavailability of Two Solid Formulations of GLPG0634",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2013-07",
      "completion_date": "2013-09",
      "enrollment": 0,
      "sponsor": "Galapagos NV"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE1": 31,
      "PHASE3": 3,
      "PHASE2": 13,
      "PHASE4": 1,
      "NA": 1,
      "": 1
    },
    "by_status": {
      "COMPLETED": 40,
      "TERMINATED": 5,
      "RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 1,
      "WITHDRAWN": 1,
      "UNKNOWN": 1
    },
    "active_trials": 3,
    "completed_trials": 40,
    "conditions": [
      "Acute Exacerbation of Remitting Relapsing Multiple Sclerosis, Clinically Isolated Syndrome",
      "Ankylosing Spondylitis",
      "Autosomal Dominant Polycystic Kidney Disease",
      "Bioavailability",
      "Colitis, Ulcerative",
      "Cutaneous Lupus Erythematosus",
      "Cystic Fibrosis",
      "Fistulizing Crohn's Disease",
      "Healthy",
      "Healthy, Dermatitis, Atopic",
      "Healthy, Psoriasis",
      "Idiopathic Pulmonary Fibrosis",
      "Osteoarthritis",
      "Psoriatic Arthritis",
      "Rheumatoid Arthritis",
      "Systemic Lupus Erythematosus",
      "Ulcerative Colitis"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:38.351057",
    "search_query": "Galapagos NV",
    "url": "https://clinicaltrials.gov/search?term=Galapagos+NV"
  }
}